-+ 0.00%
-+ 0.00%
-+ 0.00%

*Artiva Biotherapeutics: FDA Interaction to Discuss Potential Pivotal Trial Design for AlloNK Expected in 1H >ARTV

Dow Jones·03/10/2026 20:20:00

Please log in to view news